hydralazine has been researched along with celecoxib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aldib, I; Chikh Alard, I; De Carvalho, A; Dufrasne, F; Flemmig, J; Furtmüller, PG; Gelbcke, M; Mathieu, V; Meyer, F; Nève, J; Obinger, C; Prévost, M; Rousseau, A; Soubhye, J; Tadrent, S; Van Antwerpen, P; Zouaoui Boudjeltia, K | 1 |
1 review(s) available for hydralazine and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for hydralazine and celecoxib
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
Topics: Benzimidazoles; Cell Line; Databases, Chemical; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutamic Acid; Glutamine; Guanidines; Humans; Hydrogen Peroxide; Kinetics; Lactoperoxidase; Lipoproteins, LDL; Models, Chemical; Molecular Docking Simulation; Neutrophils; Oxidation-Reduction; Peroxidase; Quinazolines; Stereoisomerism | 2017 |